Lexicon Pharmaceuticals Inc (LXRX) financials · rev $49.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Lexicon Pharmaceuticals Inc (LXRX) rev $49.8M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $49.8M | $31.1M |
| Cost of Revenue | $274.0K | $616.0K |
| Gross Profit | $49.5M | $30.5M |
| Operating Income | -$48.9M | -$197.1M |
| Net Income | -$50.3M | -$200.4M |
| EPS (Diluted) | -$0.14 | -$0.63 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $185.0M | $298.4M |
| Current Assets | $101.9M | $246.2M |
| Cash & Equivalents | $34.3M | $66.7M |
| Inventory | $281.0K | $231.0K |
| PP&E | $1.86M | $2.48M |
| Total Liabilities | $77.4M | $152.5M |
| Current Liabilities | $20.9M | $45.2M |
| Short-term Debt | $4.59M | N/A |
| Long-term Debt | $49.4M | $100.3M |
| Total Debt | $54.0M† | $100.3M† |
| Shareholders' Equity | $107.5M | $145.9M |
| Retained Earnings | -$2.02B | -$1.97B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$67.9M | -$178.8M |
| CapEx | N/A | $1.03M |
| Investing Cash Flow | $113.0M | -$15.4M |
| Financing Cash Flow | -$48.5M | $238.3M |
| Net Change in Cash | -$3.33M | $44.2M |
| Free Cash Flow | -$67.9M | -$179.8M |
FAQ
What is LXRX P/E and revenue?
Lexicon Pharmaceuticals Inc (LXRX) rev $49.8M.
What is LXRX revenue?
Lexicon Pharmaceuticals Inc last cached revenue is $49.8M (FY2025).
Is LXRX profitable?
Lexicon Pharmaceuticals Inc last cached net income is -$50.3M (FY2025).
What are LXRX total assets?
Lexicon Pharmaceuticals Inc last cached total assets are $185.0M (FY2025).
What is LXRX free cash flow?
Lexicon Pharmaceuticals Inc last cached free cash flow is -$67.9M (FY2025).
Not investment advice. Cached statements, not a live tape.